PD-L1+ tumor cells (n = 1) and strong (R2+ and R3+) reaction of PD-L1+ histiocytes/dendritic cells (n = 8) were found in nine sEBV+ TCL patients (75%). This evidence concerns the gene CD274 and neoplasm.